Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
Announcing Investor Connect Plus: A LaunchBio x…
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…
BIO Statement on Reintroduction of the PASTEUR Act
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
All Press Releases
  • Show All
Search
Results
Event Tags
April 8, 2023
A federal judge in Texas rules this week to suspend the FDA’s approval of mifepristone. BIO interim President and CEO, Rachel King, released the following statement:  “The preliminary ruling by a federal judge in Texas is an assault on science…
March 30, 2023
Healthcare Ready, Biotechnology Innovation Organization, and Wakefield Research release data Washington (March 30, 2023) -- The last several years have shown that preparing for a public health emergency is vital to protect the public, our…
March 17, 2023
Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…
March 15, 2023
Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General…
March 13, 2023
"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB…
March 9, 2023
President Biden today unveiled details of the White House’s budget request that included drastic changes to the Medicare program, including further expanding the program’s new authority to institute price controls in Medicare. BIO Chief Advocacy…
March 9, 2023
A broad coalition of national and state agriculture and bioscience organizations have written President Biden to thank the administration for beginning technical consultations with Mexico concerning its action to ban imports of biotech corn. The…
March 6, 2023
The Biotechnology Innovation Organization appreciates that USDA and the Biden Administration are aiming to increase access to modern, innovative seeds. We are reviewing USDA’s report, “More and Better Choices for Farmers: Promoting Fair Competition…
March 6, 2023
The Biotechnology Innovation Organization welcomes today’s announcement by the Office of the U.S. Trade Representative that it is initiating a technical consultation with Mexico over that country’s plan to ban imports of biotech corn. “BIO applauds…
February 28, 2023
Spring 2023 Season Takes a Deep Dive Into Pain Therapies, Artificial Intelligence, FDA’s Accelerated Approvals, and Misinformation   Today, the Biotechnology Innovation Organization (BIO) premieres its new I am BIO podcast season, which tells…